|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cancer in Ukraine 2012–2013, . Bulletin of
National Cancer Registry of Ukraine №15. 17–10. 2017
|
|
3
|
Rao AR, Motiwala HG and Karim OM: The
discovery of prostate-specific antigen. BJU Int. 101:5–10.
2008.PubMed/NCBI
|
|
4
|
Nogueira L, Corradi R and Eastham JA:
Prostatic specific antigen for prostate cancer detection. Int Braz
J Urol. 35:521–532. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Loeb S and Catalona WJ: Prostate-specific
antigen in clinical practice. Cancer Lett. 249:30–39. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Walter LC, Fung KZ, Kirby KA, Shi Y,
Espaldon R, O'Brien S, Freedland SJ, Powell AA and Hoffman RM:
Five-year downstream outcomes following prostate-specific antigen
screening in older men. JAMA Intern Med. 173:866–873. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thompson IM, Pauler DK, Goodman PJ, Tangen
CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford
ED, et al: Prevalence of prostate cancer among men with a
prostate-specific antigen level < or =4.0 ng per milliliter. N
Engl J Med. 350:2239–2246. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sunami E, Shinozaki M, Higano CS, Wollman
R, Dorff TB, Tucker SJ, Martinez SR, Mizuno R, Singer FR and Hoon
DS: Multimarker circulating DNA assay for assessing blood of
prostate cancer patients. Clin Chem. 55:559–567. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Frank S, Nelson P and Vasioukhin V: Recent
advances in prostate cancer research: Large-scale genomic analyses
reveal novel driver mutations and DNA repair defects. F1000Res.
7(pii): F1000 Faculty Rev. –1173. 2018.
|
|
10
|
Barbieri CE, Bangma CH, Bjartell A, Catto
JW, Culig Z, Grönberg H, Luo J, Visakorpi T and Rubin MA: The
mutational landscape of prostate cancer. Eur Urol. 64:567–576.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Massie CE, Mills IG and Lynch AG: The
importance of DNA methylation in prostate cancer development. J
Steroid Biochem Mol Biol. 166:1–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee WH, Isaacs WB, Bova GS and Nelson WG:
CG island methylation changes near the GSTP1 gene in prostatic
carcinoma cells detected using the polymerase chain reaction: A new
prostate cancer biomarker. Cancer Epidemiol Biomarkers Prev.
6:443–450. 1997.PubMed/NCBI
|
|
13
|
Li LC: Epigenetics of prostate cancer.
Front Biosci. 12:3377–3397. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wan JCM, Massie C, Garcia-Corbacho J,
Mouliere F, Brenton JD, Caldas C, Pacey S, Baird R and Rosenfeld N:
Liquid biopsies come of age: Towards implementation of circulating
tumour DNA. Nat Rev Cancer. 17:223–238. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Salvi S, Martignano F, Molinari C, Gurioli
G, Calistri D, De Giorgi U, Conteduca V and Casadio V: The
potential use of urine cell free DNA as a marker for cancer. Expert
Rev Mol Diagn. 16:1283–1290. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zancan M, Galdi F, Di Tonno F, Mazzariol
C, Orlando C, Malentacchi F, Agostini M, Maran M, Del Bianco P,
Fabricio AS, et al: Evaluation of cell-free DNA in urine as a
marker for bladder cancer diagnosis. Int J Biol Markers.
24:147–155. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Su YH, Wang M, Brenner DE, Ng A, Melkonyan
H, Umansky S, Syngal S and Block TM: Human urine contains small,
150 to 250 nucleotide-sized, soluble DNA derived from the
circulation and may be useful in the detection of colorectal
cancer. J Mol Diagn. 6:101–107. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xia Y, Huang CC, Dittmar R, Du M, Wang Y,
Liu H, Shenoy N, Wang L and Kohli M: Copy number variations in
urine cell free DNA as biomarkers in advanced prostate cancer.
Oncotarget. 7:35818–35831. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bryzgunova OE, Morozkin ES, Yarmoschuk SV,
Vlassov VV and Laktionov PP: Methylation-specific sequencing of
GSTP1 gene promoter in circulating/extracellular DNA from blood and
urine of healthy donors and prostate cancer patients. Ann N Y Acad
Sci. 1137:222–225. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cairns P, Esteller M, Herman JG,
Schoenberg M, Jeronimo C, Sanchez-Cespedes M, Chow NH, Grasso M, Wu
L, Westra WB and Sidransky D: Molecular detection of prostate
cancer in urine by GSTP1 hypermethylation. Clin Cancer Res.
7:2727–2730. 2001.PubMed/NCBI
|
|
21
|
Goessl C, Müller M, Heicappell R, Krause
H, Straub B, Schrader M and Miller K: DNA-based detection of
prostate cancer in urine after prostatic massage. Urology.
58:335–338. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Salvi S, Gurioli G, Martignano F, Foca F,
Gunelli R, Cicchetti G, De Giorgi U, Zoli W, Calistri D and Casadio
V: Urine cell-free DNA integrity analysis for early detection of
prostate cancer patients. Dis Markers. 2015:5741202015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takayama K, Suzuki T, Tsutsumi S, Fujimura
T, Takahashi S, Homma Y, Urano T, Aburatani H and Inoue S:
Integrative analysis of FOXP1 function reveals a tumor-suppressive
effect in prostate cancer. Mol Endocrinol. 28:2012–2024. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Calvo R, West J, Franklin W, Erickson P,
Bemis L, Li E, Helfrich B, Bunn P, Roche J, Brambilla E, et al:
Altered HOX and WNT7A expression in human lung cancer. Proc Natl
Acad Sci USA. 97:12776–12781. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bhatlekar S, Fields JZ and Boman BM: HOX
genes and their role in the development of human cancers. J Mol Med
(Berl). 92:811–823. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Daly CS, Shaw P, Ordonez LD, Williams GT,
Quist J, Grigoriadis A, Van Es JH, Clevers H, Clarke AR and Reed
KR: Functional redundancy between Apc and Apc2 regulates tissue
homeostasis and prevents tumorigenesis in murine mammary
epithelium. Oncogene. 36:1793–1803. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Phin S, Moore MW and Cotter PD: Genomic
rearrangements of PTEN in prostate cancer. Front Oncol. 3:2402013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ding W, Zhang J, Yoon JG, Shi D, Foltz G
and Lin B: NDRG4 is downregulated in glioblastoma and inhibits cell
proliferation. OMICS. 16:263–267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kang GH, Lee S, Lee HJ and Hwang KS:
Aberrant CpG island hypermethylation of multiple genes in prostate
cancer and prostatic intraepithelial neoplasia. J Pathol.
202:233–240. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kondratov AG, Stoliar LA, Kvasha SM,
Gordiyuk VV, Zgonnyk YM, Gerashchenko AV, Vozianov AF, Rynditch AV,
Zabarovsky ER and Kashuba VI: Methylation pattern of the putative
tumor-suppressor gene LRRC3B promoter in clear cell renal cell
carcinomas. Mol Med Rep. 5:509–512. 2012.PubMed/NCBI
|
|
31
|
Chen N and Zhou Q: The evolving Gleason
grading system. Chin J Cancer Res. 28:58–64. 2016.PubMed/NCBI
|
|
32
|
Schröder FH, Hermanek P, Denis L, Fair WR,
Gospodarowicz MK and Pavone-Macaluso M: The TNM classification of
prostate cancer. Prostate Suppl. 4:129–138. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hessels D, Klein Gunnewiek JM, van Oort I,
Karthaus HF, van Leenders GJ, van Balken B, Kiemeney LA, Witjes JA
and Schalken JA: DD3(PCA3)-based molecular urine analysis for the
diagnosis of prostate cancer. Eur Urol. 44:8–16. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hoque MO, Topaloglu O, Begum S, Henrique
R, Rosenbaum E, Van Criekinge W, Westra WH and Sidransky D:
Quantitative methylation-specific polymerase chain reaction gene
patterns in urine sediment distinguish prostate cancer patients
from control subjects. J Clin Oncol. 23:6569–6575. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rouprêt M, Hupertan V, Yates DR, Catto JW,
Rehman I, Meuth M, Ricci S, Lacave R, Cancel-Tassin G, de la Taille
A, et al: Molecular detection of localized prostate cancer using
quantitative methylation-specific PCR on urinary cells obtained
following prostate massage. Clin Cancer Res. 13:1720–1725. 2007.
View Article : Google Scholar : PubMed/NCBI
|
